• No results found

[PDF] Top 20 How does the efficacy and safety of Oralair<sup>&reg;</sup> compare to other products on the market?

Has 10000 "How does the efficacy and safety of Oralair<sup>&reg;</sup> compare to other products on the market?" found on our website. Below are the top 20 most common "How does the efficacy and safety of Oralair<sup>&reg;</sup> compare to other products on the market?".

How does the efficacy and safety of Oralair&lt;sup&gt;&amp;reg;&lt;/sup&gt; compare to other products on the market?

How does the efficacy and safety of Oralair<sup>&reg;</sup> compare to other products on the market?

... in comparison with the placebo, even at 1 week, but the difference reached statistical significance by the 1-month challenge. At months 2 and 4, the difference in symptoms score improvement during challenge between ... See full document

20

Efficacy and safety of iron isomaltoside (Monofer&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in the management of patients with iron deficiency anemia

Efficacy and safety of iron isomaltoside (Monofer<sup>&reg;</sup>) in the management of patients with iron deficiency anemia

... to fulfill these requirements. Iron isomaltoside has been shown to be effective in treating iron deficiency anemia across multiple therapeutic patient groups and compared to placebo, IV iron sucrose, and oral iron. Iron ... See full document

12

&lt;p&gt;An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic&lt;sup&gt;&amp;reg;&lt;/sup&gt;/ Combogesic&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in adults&lt;/p&gt;

<p>An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic<sup>&reg;</sup>/ Combogesic<sup>&reg;</sup>) in adults</p>

... of safety. Among a pooled safety population of 922 patients, 521 AEs were ...analgesic efficacy obtained by combining APAP and IBP did not come at the expense of safety or ...FDC does ... See full document

14

Comparison of outcomes of conventional WaveLight&lt;sup&gt;&amp;reg;&lt;/sup&gt; Allegretto Wave&lt;sup&gt;&amp;reg;&lt;/sup&gt; and Technolas&lt;sup&gt;&amp;reg;&lt;/sup&gt; excimer lasers in myopic laser in situ keratomileusis

Comparison of outcomes of conventional WaveLight<sup>&reg;</sup> Allegretto Wave<sup>&reg;</sup> and Technolas<sup>&reg;</sup> excimer lasers in myopic laser in situ keratomileusis

... cylinder, safety and efficacy indices, refractive predictability, and optical zone size ...Mean safety and efficacy indices were ...MRSE, safety and efficacy indices between the ... See full document

10

Tobramycin administered by the TOBI&lt;sup&gt;&amp;reg;&lt;/sup&gt; Podhaler&lt;sup&gt;&amp;reg;&lt;/sup&gt; for persons with cystic fibrosis: a review

Tobramycin administered by the TOBI<sup>&reg;</sup> Podhaler<sup>&reg;</sup> for persons with cystic fibrosis: a review

... the safety and efficacy of chronic oral fluoroquinolones in ...the safety and efficacy of both oral and IV suppressive antibiotic therapies are limited by a com- mon problem: use of the ... See full document

10

Efficacy and tolerability of Laxatan&lt;sup&gt;&amp;reg;&lt;/sup&gt; Granulat in patients with chronic constipation

Efficacy and tolerability of Laxatan<sup>&reg;</sup> Granulat in patients with chronic constipation

... Constipation is defined by infrequent bowel movements, typically only every three to four days a week, difficulties during defecation, and is associated with hard stool, pain, strong pressing, and the sensation of ... See full document

6

Developments in administration of growth hormone treatment: focus on Norditropin&lt;sup&gt;&amp;reg;&lt;/sup&gt; Flexpro&lt;sup&gt;&amp;reg;&lt;/sup&gt;

Developments in administration of growth hormone treatment: focus on Norditropin<sup>&reg;</sup> Flexpro<sup>&reg;</sup>

... A growth hormone-loaded hyaluronate microparticle (LB03002), which was developed and launched as a once- a-week injection formulation in Korea by LG Life Sciences in 2007, is the only commercially available ... See full document

8

Efficacy and safety of tiotropium Respimat&lt;sup&gt;&amp;reg;&lt;/sup&gt; SMI in COPD in two 1-year randomized studies

Efficacy and safety of tiotropium Respimat<sup>&reg;</sup> SMI in COPD in two 1-year randomized studies

... Cardiovascular safety was monitored in a subset of patients using 12-lead electrocardiogram (ECG) and Holter monitoring; these measures were performed at randomization, week 16, and week ... See full document

12

The NordiNet&lt;sup&gt;&amp;reg;&lt;/sup&gt; International Outcome Study and NovoNet&lt;sup&gt;&amp;reg;&lt;/sup&gt; ANSWER Program&lt;sup&gt;&amp;reg;&lt;/sup&gt;: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and s

The NordiNet<sup>&reg;</sup> International Outcome Study and NovoNet<sup>&reg;</sup> ANSWER Program<sup>&reg;</sup>: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin<sup>&reg;</sup>)

... into the effectiveness and safety of GH treatment across a diverse and large patient population treated in accordance with real-world clinical practice and following the Good Pharmacoep[r] ... See full document

9

An integrated safety analysis of intravenous ibuprofen (Caldolor&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in adults

An integrated safety analysis of intravenous ibuprofen (Caldolor<sup>&reg;</sup>) in adults

... integrated safety database comprising data from the studies listed in Table 1 was ...the safety database was generated by combining the study data tabulation model tagged datasets from each individual study ... See full document

13

Patients&amp;rsquo; perspectives and preferences in the choice of inhalers: the case for Respimat&lt;sup&gt;&amp;reg; &lt;/sup&gt;or HandiHaler&lt;sup&gt;&amp;reg;&lt;/sup&gt;

Patients&rsquo; perspectives and preferences in the choice of inhalers: the case for Respimat<sup>&reg; </sup>or HandiHaler<sup>&reg;</sup>

... the efficacy of drug therapy in asthma and chronic obstructive pulmonary ...only does this affect individual patient care, but it also impacts on the wider health care economics associated with these ... See full document

12

An evaluation of the accuracy of the ORange&lt;sup&gt;&amp;reg;&lt;/sup&gt; (Gen II) by comparing it to the IOLMaster&lt;sup&gt;&amp;reg;&lt;/sup&gt; in the prediction of postoperative refraction

An evaluation of the accuracy of the ORange<sup>&reg;</sup> (Gen II) by comparing it to the IOLMaster<sup>&reg;</sup> in the prediction of postoperative refraction

... with the same power that the IOLMaster selected were used and the predicted postoperative SE refraction was recorded. One month later, the patients were examined for a manifest refraction by the technician and the SE ... See full document

5

A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl&lt;sup&gt;&amp;reg;&lt;/sup&gt;) with the ON-Q PainBuster&lt;sup&gt;&amp;reg;&lt;/sup&gt; Post-op Pain Relief System following open gynecological surgery

A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl<sup>&reg;</sup>) with the ON-Q PainBuster<sup>&reg;</sup> Post-op Pain Relief System following open gynecological surgery

... An independent statistician created and maintained a computer-generated randomization schedule which was used by the contractor (Aptuit, Kansas City, MO) responsible for packaging and labeling the clinical supplies, to ... See full document

9

Long-term safety of tiotropium/olodaterol Respimat&lt;sup&gt;&amp;reg;&lt;/sup&gt;&amp;nbsp;in patients with moderate-to-very severe COPD and renal impairment in the TONADO&lt;sup&gt;&amp;reg;&lt;/sup&gt; studies

Long-term safety of tiotropium/olodaterol Respimat<sup>&reg;</sup>&nbsp;in patients with moderate-to-very severe COPD and renal impairment in the TONADO<sup>&reg;</sup> studies

... financial support from Boehringer Ingelheim and Novartis to perform clinical studies; he has participated in advisory boards for Boehringer Ingelheim, Chiesi, Cipla, Novartis, and AstraZeneca, for which a fee was given ... See full document

13

Dose comparison of conivaptan (Vaprisol&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in patients with euvolemic or hypervolemic hyponatremia &amp;ndash; efficacy, safety, and pharmacokinetics

Dose comparison of conivaptan (Vaprisol<sup>&reg;</sup>) in patients with euvolemic or hypervolemic hyponatremia &ndash; efficacy, safety, and pharmacokinetics

... In this study, over 70% of patients treated with either 20 or 40 mg/day conivaptan reached the treatment goal of either a normal sNa measurement or an increase of at least 6 mEq/L from baseline. Seemingly small increases ... See full document

13

A placebo-controlled, double-blind clinical trial to evaluate the efficacy of Imedeen&lt;sup&gt;&amp;reg;&lt;/sup&gt; Time Perfection&lt;sup&gt;&amp;reg;&lt;/sup&gt; for improving the appearance of photodamaged skin

A placebo-controlled, double-blind clinical trial to evaluate the efficacy of Imedeen<sup>&reg;</sup> Time Perfection<sup>&reg;</sup> for improving the appearance of photodamaged skin

... The subjects returned to the study site at approximately week 12 (visit 5) for compliance assessments and efficacy evaluations, including clinical grading, photography, instru- mentation, and self-assessments. The ... See full document

8

Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis&lt;sup&gt;&amp;reg;&lt;/sup&gt; noncontact ultra-widefield module versus the Optos&lt;sup&gt;&amp;reg;&lt;/sup&gt; Optomap&lt;sup&gt;&amp;reg;&lt;/sup&gt;

Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis<sup>&reg;</sup> noncontact ultra-widefield module versus the Optos<sup>&reg;</sup> Optomap<sup>&reg;</sup>

... Clinical Ophthalmology is an international, peer-reviewed journal covering all subspecialties within ophthalmology. Key topics include: Optometry; Visual science; Pharmacology and drug therapy in eye diseases; Basic ... See full document

6

Asthma patients prefer Respimat&lt;sup&gt;&amp;reg;&lt;/sup&gt; Soft Mist&lt;sup&gt;&amp;trade;&lt;/sup&gt; Inhaler to Turbuhaler&lt;sup&gt;&amp;reg;&lt;/sup&gt;

Asthma patients prefer Respimat<sup>&reg;</sup> Soft Mist<sup>&trade;</sup> Inhaler to Turbuhaler<sup>&reg;</sup>

... it does appear that in real life conditions, choice of inhaler device can have an impact on treatment adherence and disease control, and that the patient/device interface is crucial, for both asthma ... See full document

8

Long-term efficacy, safety and durability of Juv&amp;eacute;derm&lt;sup&gt;&amp;reg;&lt;/sup&gt; XC

Long-term efficacy, safety and durability of Juv&eacute;derm<sup>&reg;</sup> XC

... Abstract: Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is ... See full document

7

&lt;p&gt;Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO&lt;sup&gt;&amp;reg;&lt;/sup&gt; and OTEMTO&lt;sup&gt;&amp;reg;&lt;/sup&gt; studies: a subgroup analysis by age&lt;/p&gt;

<p>Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO<sup>&reg;</sup> and OTEMTO<sup>&reg;</sup> studies: a subgroup analysis by age</p>

... conditions other than COPD that could have affected the outcome of a patient, influenced the results of the studies, or caused concern regarding a patient’s ability to ... See full document

10

Show all 10000 documents...